Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Indinavir (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Saquinavir (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Nelfinavir (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
retroviral proteaseinhibitor |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Product containing abacavir (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Product containing abacavir and lamivudine and zidovudine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Abacavir sulfate 300mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Abacavir sulfate 20mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Ritonavir (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Amprenavir (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Lopinavir (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
abacavirsulfat 300 mg + lamivudin 150 mg + zidovudin 300 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Abacavir sulfate + lamivudine + zidovudine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Atazanavir sulfate (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Fosamprenavir (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
abacavir 300 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Abacavir (as abacavir sulfate) 20 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
abacavirsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Atazanavir (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
abacavir og derivater |
Is a |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Tipranavir (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Darunavir (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Boceprevir (substance) |
Is a |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Telaprevir |
Is a |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Simeprevir (substance) |
Is a |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Cobicistat |
Is a |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Allergy to protease inhibitor (finding) |
Causative agent |
True |
Protease inhibitor |
Inferred relationship |
Some |
1 |
Steatosis of liver caused by retroviral protease inhibitor |
Causative agent |
True |
Protease inhibitor |
Inferred relationship |
Some |
1 |
Asunaprevir (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Product containing protease inhibitor (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Protease inhibitor |
Inferred relationship |
Some |
1 |
Abacavir (substance) |
Is a |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Abacavir sulfate (substance) |
Is a |
False |
Protease inhibitor |
Inferred relationship |
Some |
|
Saquinavir mesilate |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Nelfinavir mesilate |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Indinavir sulfate |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Hepatitis C virus NS3/4A protease inhibitor |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Fosamprenavir calcium (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Darunavir ethanolate (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Darunavir propylene glycolate |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Ecadotril |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|
Substance with Severe acute respiratory syndrome coronavirus main protease inhibitor mechanism of action (substance) |
Is a |
True |
Protease inhibitor |
Inferred relationship |
Some |
|